Clinical Trial Update: Omega-3 Supplementation for Tetraplegics With Poor Cholesterol Levels [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating omega-3 fatty acid supplementation in tetraplegic patients with dyslipidemia; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Spinal Cord Injury
• Tetraplegia

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: University of Manitoba | Conditions: Spinal Cord Injury, Tetraplegia | Phase 4 | Status: COMPLETED